Annual Short Term Debt
$298.70 K
+$25.70 K+9.41%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual short term debt is $298.70 thousand, with the most recent change of +$25.70 thousand (+9.41%) on December 1, 2023.
- During the last 3 years, CSCI annual short term debt has risen by +$45.50 thousand (+17.97%).
- CSCI annual short term debt is now -88.63% below its all-time high of $2.63 million, reached on December 1, 1996.
Performance
CSCI Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$405.00 K
-$2000.00-0.49%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly short term debt is $405.00 thousand, with the most recent change of -$2000.00 (-0.49%) on September 1, 2024.
- Over the past year, CSCI quarterly short term debt has increased by +$106.30 thousand (+35.59%).
- CSCI quarterly short term debt is now -85.28% below its all-time high of $2.75 million, reached on September 1, 1997.
Performance
CSCI Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
CSCI Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9.4% | +35.6% |
3 y3 years | +18.0% | +35.6% |
5 y5 years | -0.7% | +35.6% |
CSCI Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +31.3% | -0.5% | +78.0% |
5 y | 5-year | -13.3% | +31.3% | -0.5% | +78.0% |
alltime | all time | -88.6% | +482.3% | -85.3% | +2369.5% |
COSCIENS Biopharma Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $405.00 K(-0.5%) |
Jun 2024 | - | $407.00 K(+37.0%) |
Mar 2024 | - | $297.00 K(-0.6%) |
Dec 2023 | $298.70 K(+9.4%) | $298.70 K(+3.8%) |
Sep 2023 | - | $287.80 K(-1.3%) |
Jun 2023 | - | $291.50 K(+3.4%) |
Mar 2023 | - | $282.00 K(+3.3%) |
Dec 2022 | $273.00 K(+20.0%) | $273.00 K(+19.2%) |
Sep 2022 | - | $229.10 K(-2.7%) |
Jun 2022 | - | $235.40 K(+0.1%) |
Mar 2022 | - | $235.10 K(+3.3%) |
Dec 2021 | $227.50 K(-10.2%) | $227.50 K(-21.0%) |
Sep 2021 | - | $288.10 K(-1.1%) |
Jun 2021 | - | $291.20 K(+9.6%) |
Mar 2021 | - | $265.60 K(+4.9%) |
Dec 2020 | $253.20 K(-26.5%) | $253.20 K(-5.0%) |
Sep 2020 | - | $266.40 K(-0.4%) |
Jun 2020 | - | $267.60 K(-7.0%) |
Mar 2020 | - | $287.80 K(-16.4%) |
Dec 2019 | $344.40 K(+14.5%) | $344.40 K(-9.6%) |
Sep 2019 | - | $381.10 K(-5.5%) |
Jun 2019 | - | $403.10 K(-2.3%) |
Mar 2019 | - | $412.50 K(+37.1%) |
Dec 2018 | $300.90 K(-59.5%) | $300.90 K(-33.1%) |
Sep 2018 | - | $449.90 K(-20.7%) |
Jun 2018 | - | $567.10 K(-17.3%) |
Mar 2018 | - | $686.10 K(-7.6%) |
Dec 2017 | $742.60 K(-6.9%) | $742.60 K(-6.3%) |
Sep 2017 | - | $792.20 K(-14.9%) |
Jun 2017 | - | $930.70 K(+17.6%) |
Mar 2017 | - | $791.30 K(-1.1%) |
Dec 2016 | $797.50 K(-42.6%) | $799.90 K(-48.0%) |
Sep 2016 | - | $1.54 M(+0.5%) |
Jun 2016 | - | $1.53 M(+1.6%) |
Mar 2016 | - | $1.51 M(+8.4%) |
Dec 2015 | $1.39 M(+91.9%) | $1.39 M(+77.0%) |
Sep 2015 | - | $785.80 K(-0.2%) |
Jun 2015 | - | $787.30 K(+13.7%) |
Mar 2015 | - | $692.60 K(-4.4%) |
Dec 2014 | $724.70 K(+34.8%) | $724.70 K(-2.9%) |
Sep 2014 | - | $746.00 K(-1.2%) |
Jun 2014 | - | $754.70 K(+21.5%) |
Mar 2014 | - | $621.40 K(+15.5%) |
Dec 2013 | $537.80 K(+217.3%) | $537.80 K(+219.0%) |
Sep 2013 | - | $168.60 K(+2.9%) |
Jun 2013 | - | $163.80 K(-2.4%) |
Mar 2013 | - | $167.80 K(-1.0%) |
Dec 2012 | $169.50 K(+12.0%) | $169.50 K(-82.7%) |
Sep 2012 | - | $981.40 K(-0.7%) |
Jun 2012 | - | $987.90 K(-5.5%) |
Mar 2012 | - | $1.05 M(+591.0%) |
Dec 2011 | $151.30 K(-75.4%) | $151.30 K(-75.6%) |
Sep 2011 | - | $619.90 K(-4.9%) |
Jun 2011 | - | $651.70 K(+1.6%) |
Mar 2011 | - | $641.40 K(+4.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $613.80 K(+366.1%) | $613.80 K(+377.3%) |
Sep 2010 | - | $128.60 K(-4.9%) |
Jun 2010 | - | $135.20 K(-2.0%) |
Mar 2010 | - | $138.00 K(+4.1%) |
Dec 2009 | $131.70 K(-49.1%) | $132.60 K(-4.3%) |
Sep 2009 | - | $138.50 K(+19.0%) |
Jun 2009 | - | $116.40 K(+10.2%) |
Mar 2009 | - | $105.60 K(-59.7%) |
Dec 2008 | $258.60 K(+129.1%) | $261.80 K(+113.5%) |
Sep 2008 | - | $122.60 K(-2.6%) |
Jun 2008 | - | $125.90 K(+16.8%) |
Mar 2008 | - | $107.80 K(-5.2%) |
Dec 2007 | $112.90 K(+80.6%) | $113.70 K(+42.1%) |
Sep 2007 | - | $80.00 K(-2.4%) |
Jun 2007 | - | $82.00 K(+53.0%) |
Mar 2007 | - | $53.60 K(-14.4%) |
Dec 2006 | $62.50 K(-36.9%) | $62.60 K(-57.2%) |
Sep 2006 | - | $146.20 K(+72.6%) |
Jun 2006 | - | $84.70 K(-3.1%) |
Mar 2006 | - | $87.40 K(-11.8%) |
Dec 2005 | $99.00 K(-29.2%) | $99.10 K(-7.9%) |
Sep 2005 | - | $107.60 K(-2.1%) |
Jun 2005 | - | $109.90 K(-17.6%) |
Mar 2005 | - | $133.40 K(-4.6%) |
Dec 2004 | $139.80 K(-13.2%) | $139.80 K(-5.3%) |
Sep 2004 | - | $147.60 K(+120.6%) |
Jun 2004 | - | $66.90 K(+8.4%) |
Mar 2004 | - | $61.70 K(-61.7%) |
Dec 2003 | $161.00 K(+50.7%) | $161.30 K(+112.8%) |
Sep 2003 | - | $75.80 K(-11.9%) |
Jun 2003 | - | $86.00 K(-9.2%) |
Mar 2003 | - | $94.70 K(-11.6%) |
Dec 2002 | $106.80 K(+108.2%) | $107.10 K(+100.9%) |
Sep 2002 | - | $53.30 K(-3.4%) |
Jun 2002 | - | $55.20 K(+6.2%) |
Mar 2002 | - | $52.00 K(+1.0%) |
Dec 2001 | $51.30 K(-76.4%) | $51.50 K(-2.8%) |
Sep 2001 | - | $53.00 K(-3.3%) |
Jun 2001 | - | $54.80 K(+8.1%) |
Mar 2001 | - | $50.70 K(-76.7%) |
Dec 2000 | $217.00 K(-36.9%) | $217.20 K(+1224.4%) |
Sep 2000 | - | $16.40 K(-97.0%) |
Jun 2000 | - | $540.10 K(+292.2%) |
Mar 2000 | - | $137.70 K(-60.1%) |
Dec 1999 | $343.90 K(+77.5%) | $345.20 K(+69.0%) |
Sep 1999 | - | $204.30 K(+54.2%) |
Mar 1999 | - | $132.50 K(-32.1%) |
Dec 1998 | $193.80 K(-74.7%) | $195.00 K(-25.6%) |
Sep 1998 | - | $262.00 K(-35.8%) |
Jun 1998 | - | $408.40 K(+16.0%) |
Mar 1998 | - | $352.20 K(-54.2%) |
Dec 1997 | $767.50 K(-70.8%) | $768.70 K(-72.1%) |
Sep 1997 | - | $2.75 M(+18.7%) |
Jun 1997 | - | $2.32 M(-5.9%) |
Mar 1997 | - | $2.46 M |
Dec 1996 | $2.63 M | - |
FAQ
- What is COSCIENS Biopharma annual short term debt?
- What is the all time high annual short term debt for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual short term debt year-on-year change?
- What is COSCIENS Biopharma quarterly short term debt?
- What is the all time high quarterly short term debt for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly short term debt year-on-year change?
What is COSCIENS Biopharma annual short term debt?
The current annual short term debt of CSCI is $298.70 K
What is the all time high annual short term debt for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual short term debt is $2.63 M
What is COSCIENS Biopharma annual short term debt year-on-year change?
Over the past year, CSCI annual short term debt has changed by +$25.70 K (+9.41%)
What is COSCIENS Biopharma quarterly short term debt?
The current quarterly short term debt of CSCI is $405.00 K
What is the all time high quarterly short term debt for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly short term debt is $2.75 M
What is COSCIENS Biopharma quarterly short term debt year-on-year change?
Over the past year, CSCI quarterly short term debt has changed by +$106.30 K (+35.59%)